CSF2RB Gene Surfactant Metabolism Dysfunction Type 5 Genetic Test
Welcome to DNA Labs UAE, where we offer the CSF2RB Gene Surfactant Metabolism Dysfunction Type 5 Genetic Test. This test helps in the diagnosis of surfactant metabolism dysfunction type 5 (SMDP5) caused by mutations in the CSF2RB gene. Let’s dive into the details:
Test Components
This genetic test includes:
- CSF2RB Gene Surfactant Metabolism Dysfunction Type 5 Genetic Test
Price
The cost of this test is 4400.0 AED.
Sample Condition
We accept the following sample conditions:
- Blood
- Extracted DNA
- One drop of blood on FTA Card
Report Delivery
You can expect to receive your test report within 3 to 4 weeks.
Method
We use NGS (Next-Generation Sequencing) technology for this genetic test.
Test Type
This test falls under the category of Metabolic Disorders.
Doctor
Your test will be conducted by a General Physician.
Test Department
This test is conducted in our Genetics department.
Pre Test Information
Prior to the test, we require the clinical history of the patient who is going for the CSF2RB Gene Surfactant Metabolism Dysfunction Type 5 NGS Genetic DNA Test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with Surfactant Metabolism Dysfunction Type 5.
Test Details
The CSF2RB gene encodes a protein called granulocyte-macrophage colony-stimulating factor receptor beta (GM-CSF receptor beta). Mutations in the CSF2RB gene can lead to surfactant metabolism dysfunction type 5 (SMDP5), a rare genetic disorder that affects the production and function of pulmonary surfactant. Pulmonary surfactant is essential for reducing surface tension in the lungs and facilitating efficient breathing. Impaired surfactant metabolism can result in respiratory distress and other lung-related problems.
NGS genetic testing is a state-of-the-art genetic test that allows for the simultaneous analysis of multiple genes or the entire genome. In the case of SMDP5 caused by CSF2RB gene mutations, NGS technology can identify genetic variations or mutations associated with the condition. This information aids in the diagnosis of SMDP5 and provides insights into the specific genetic changes responsible for the disease. Understanding the underlying cause of the disease, predicting disease progression, and guiding treatment decisions are the key benefits of NGS genetic testing for CSF2RB gene mutations.
Please note that genetic testing should always be done under the guidance of a healthcare professional or genetic counselor. They can interpret the test results and provide appropriate counseling and support.
| Test Name | CSF2RB Gene Surfactant metabolism dysfunction type 5 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CSF2RB Gene Surfactant metabolism dysfunction type 5 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Surfactant metabolism dysfunction type 5 |
| Test Details |
CSF2RB gene is responsible for encoding a protein called granulocyte-macrophage colony-stimulating factor receptor beta (GM-CSF receptor beta). Mutations in the CSF2RB gene can lead to a condition called surfactant metabolism dysfunction type 5 (SMDP5). Surfactant metabolism dysfunction refers to a group of rare genetic disorders that affect the production and function of pulmonary surfactant. Pulmonary surfactant is a substance that helps to reduce surface tension in the lungs and allows for efficient breathing. When surfactant metabolism is impaired, it can lead to respiratory distress and other lung-related problems. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes or the entire genome. It uses advanced sequencing technology to identify genetic variations or mutations that may be associated with a particular condition, such as SMDP5 caused by mutations in the CSF2RB gene. NGS genetic testing for CSF2RB gene mutations can help in the diagnosis of SMDP5 and provide information about the specific genetic changes that may be responsible for the condition. This information can be valuable for understanding the underlying cause of the disease, predicting disease progression, and guiding treatment decisions. It’s important to note that genetic testing should be done under the guidance of a healthcare professional or genetic counselor who can interpret the results and provide appropriate counseling and support. |
